SCHEMBL3227590

SCHEMBL3227590

Oc1cccc2ccc(Oc3ccc4cccc(O)c4n3)nc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.57
PLAU P00749 1/20 0.57
NCF1 P14598 1/20 0.57
ALOX12 P18054 3/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
HIF1A Q16665 1/20 0.55
HSD17B10 Q99714 1/20 0.55
KDM4E B2RXH2 6/20 0.52
KMT2A Q03164 6/20 0.52
SOS2 Q07890 1/20 0.52
TSHR P16473 2/20 0.50
MMP2 P08253 1/20 0.50
CHRM1 P11229 1/20 0.50
COMT P21964 1/20 0.50
ADRA1A P35348 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4624293 0.87 KDM4E (0.49) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL4624601 0.84 KMT2A (0.48) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL1043719 0.84 METAP2 (0.58) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL4626479 0.83 ALDH1A1 (0.47) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL31157799 0.82 METAP2 (0.56) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL30457998 0.82 METAP2 (0.56) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL29040599 0.82 METAP2 (0.56) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL29040602 0.82 METAP2 (0.56) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL11817511 0.82 KDM4E (0.56) METAP2PLAUNCF1ALOX12ALDH1A1
SCHEMBL4626576 0.82 MEN1 (0.56) METAP2ALOX12ALDH1A1CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318650-B2 Bis(hydroxyquinoline) metal complexes as bleach catalysts HENKEL AG & CO. KGAA (DE) 2012-11-27 US disclosed
EP-2144880-B1 BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS HENKEL AG & CO KGAA (DE) 2012-05-30 EP disclosed
US-20100048447-A1 BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS HENKEL AG & CO. KGAA (DE) 2010-02-25 US disclosed
EP-2144880-A1 BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS Henkel AG & Co. KGaA (DE) 2010-01-20 EP disclosed
WO-2008135337-A1 BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS HENKEL AG & CO. KGAA (DE) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048447-A1 BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS BLM, POLQ, HLCS METAP2 1950/4885PLAU 3589/4885NCF1 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.